CIBA Vision Corporation, the Eye Care Unit of Novartis International AG, Announces Settlement of...
biospace.com     May 21, 2008          

Duluth, Georgia, November 21, 2007 - CIBA Vision, the eye care unit of Novartis, has reached a final global patent litigation settlement agreement with CooperVision, Inc. (NYSE: COO) that resolves all current patent infringement lawsuits between the two companies. [read full story]                

Add a comment to the article
Type the code shown

View all news articles about:

- Related Topics

View other selected articles:

Headcount II: The Learned Intermediary Rule And Medical Devices

druganddevicelaw.blogspot.com     Jul 10, 2008          

Our post last month about Breen v. But whether to apply the rule, or not, turns on the presence of a prescribing physician, the presumed learned intermediary, and not on whether that physician was adequately warned in a...                

comments

The Cooper Companies Announces Results of Its Repurchase of Tendered 2.625 Percent Convertible...

primenewswire.com     Jul 1, 2008   2 related          

PLEASANTON, Calif., July 1, 2008 (PRIME NEWSWIRE) -- The Cooper Companies, Inc. (NYSE:COO) today announced the results of its offer to repurchase its 2.625% Convertible Senior Debentures due 2023 (the "Securities") pursuant to...                

comments

The Cooper Companies to Present At Jefferies Annual Healthcare Conference (PrimeNewswire)

yahoo.com     Jun 19, 2008   1 related          

Thursday June 19, 4:05 pm ET PLEASANTON, Calif., June 19, 2008 (PRIME NEWSWIRE) -- The Cooper Companies, Inc. (NYSE:COO - News ) today announced that Robert S. Weiss, President and Chief Executive Officer, will present at the...                

comments

The Cooper Companies Announces Second Quarter Results (PrimeNewswire)

yahoo.com     Jun 6, 2008          

PLEASANTON, Calif., June 5, 2008 (PRIME NEWSWIRE) -- Adjusted EPS excludes the non-GAAP adjustments as shown below in "Unaudited Reconciliation and Explanation of Non-GAAP to GAAP Operating Results." * Commenting on the...                

comments